In addition to avoiding exposure to ionizing radiation, stress cardiac MR (CMR) myocardial perfusion imaging is an effective and robust risk-stratifying tool for patients of either sex presenting with possible ischemia, according to a study in the August issue of JACC: Cardiovascular Imaging.
The Society of Cardiovascular Computed Tomography (SCCT) announced the winners of the Toshiba Young Investigator Award at the organization's sixth annual scientific meeting July 14-17.
Noninvasive cardiovascular (CV) imaging showed no benefit of improving primary prevention measures for patients; however, the authors wrote that future studies will be necessary to provide hard evidence on how these imaging tests impact prevention efforts, according to a meta-analysis published June 13 in the Archives of Internal Medicine.
In diabetic patients, fatty acid metabolism or perfusion mismatch obtained from dual SPECT using I-123 beta-methyl iodophenyl pentadecanoic acid (BMIPP)-TL, a medical isotope bound with an agent that is metabolized by the heart to image the fatty acid uptake of heart muscle cells, is a useful prognostic tool for adverse cardiac events, according to a study presented this week at the SNM’s annual meeting in San Antonio, Texas.
Written by C.P. Kaiser
SPECT myocardial perfusion imaging (MPI) is a well-validated noninvasive test to determine if coronary artery disease (CAD) is the cause of a patient’s chest pain. While SPECT will continue to play a role in this patient population, other tests are helping to fill in the gaps in identifying those at risk of cardiac events.
RSS 
